|
|
|
|
| LEADER |
02320nmm a2200397 u 4500 |
| 001 |
EB001346135 |
| 003 |
EBX01000000000000000900325 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
170223 ||| eng |
| 100 |
1 |
|
|a Raj, Nitya
|
| 245 |
0 |
0 |
|a Immunotherapy in neuroendocrine tumors
|h Elektronische Ressource
|b part 2 of 2, role of immunotherapy
|c Nitya Raj
|
| 246 |
3 |
1 |
|a Role of immunotherapy
|
| 246 |
3 |
1 |
|a Immunotherapy in neuroendocrine tumors. Part 2, Role of immunotherapy
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2017, 2017
|
| 300 |
|
|
|a 1 online resource (1 streaming video file (40 min.)
|b color, sound)
|
| 505 |
0 |
|
|a What does prior investigation in the clinic and in the lab tell us about a role for immunotherapy in NETs -- Next-generation sequencing of NETs highlighting where we may use immunotherapy -- Ongoing studies/studies in development of immunotherapy in NETs
|
| 653 |
|
|
|a Immunotherapy / trends
|
| 653 |
|
|
|a Neuroendocrine tumors / Treatment
|
| 653 |
|
|
|a Octreotide / therapeutic use
|
| 653 |
|
|
|a Immunotherapy
|
| 653 |
|
|
|a High-Throughput Nucleotide Sequencing
|
| 653 |
|
|
|a Neuroendocrine Tumors / therapy
|
| 653 |
|
|
|a Programmed Cell Death 1 Receptor / immunology
|
| 653 |
|
|
|a Lymphocytes, Tumor-Infiltrating / immunology
|
| 653 |
|
|
|a Immunotherapy / methods
|
| 653 |
|
|
|a Neuroendocrine Tumors / immunology
|
| 653 |
|
|
|a Interferon-alpha / therapeutic use
|
| 653 |
|
|
|a Neuroendocrine Tumors / genetics
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Immunotherapy of cancer
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web. - System requirements: Browser compatibility: updated Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8+. Browser settings: enable JavaScript, enable cookies from the Henry Stewart Talks site. Required Desktop Browser plugins & viewers: Updated Adobe Flash Player & Adobe Acrobat Reader. Mobile device & operating system versions: Android v4.0+, iPhone 4+ (iOS v6.x+), iPad 2+ (iOS v6.x+), BlackBerry OS v7.0+, Windows Phone v6.5.1+
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/896
|3 Series
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/3433
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|